← All companies ← ST Manual STAG → ← SSII Medical Devices & Equipment STE →
STAA, STAAR Surgical Company
STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye.
We market and sell our ICLs for refractive surgery to treat myopia (nearsightedness) as our "EVO" family of lenses.
We make our ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision).
The business
What it sells, where the money comes from, the kind of company it is.
Next report By 11/11 · the 10-Q for the quarter ended early October · due within 40 days of period end · has filed ~40 days after · the wire records it on arrival
The business in brief
read the 10-K →What this business is and what moves its needle, from its own SEC filings.
- Situation
- Cyclical. Margins collapse and recover repeatedly across the record; a single year, good or bad, misstates the through-cycle earning power.
- What moves the needle
- Gross margin has run about 75% and operating margin about 4.7% through the cycle, a wide spread between price and the cost of what it sells — whether that advantage is durable pricing power or a margin that can erode is the question the record is for. The operating margin has swung widely — from −38% to 18% — on a steadier 75% gross margin, so what moves it sits below the gross line, in operating spend and one-off charges more than in the cost of the product itself. Stock-based pay runs about 7.3% of sales, a real and recurring claim on owners that the GAAP margin understates. On its own account, the filing leans hardest on customer concentration, set against the numbers in what the filing emphasizes, below.
- Is it a good business?
- Return on capital has sat near the cost of capital (median 9%). The steadier read is owner earnings: roughly 6% of revenue reaches owners as cash, though it swings. The cycle and the balance sheet decide this one; the worst year tells more than the median, and the rest is in the 10-K.
Every line is arithmetic on the company's filings, shown in full in the sections below.
The record
Ten years of arithmetic, read across the cycle.
Revenue up 111.0% year over year
“Net sales for the three months ended July 3, 2026 increased 111.0% from the same period of 2025, primarily due to increased sales in China.”
figures computed from the filing's XBRL; the words are the company's
The record, 2016–2025
realized figures from each filing · older years to the left| 2016’16 | 2017’17 | 2018’18 | 2019’19 | 2020’20 | 2021’21 | 2022’22 | 2023’23 | 2024’24 | 2025’25 | TTMTTMJul 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||
| $82M | $91M | $124M | $150M | $163M | $230M | $239M | $322M | $314M | $239M | $340M | RevenueRevenue |
| $58M | $64M | $92M | $112M | $118M | $179M | — | $253M | $240M | $182M | $260M | Gross profitGross prof. |
| 71% | 71% | 74% | 75% | 72% | 78% | — | 78% | 76% | 76% | 77% | Gross marginGross mgn |
| 86% | 75% | 69% | 67% | 68% | 63% | 75% | 70% | 80% | 114% | 73% | SG&A / revenueSG&A/rev |
| 25% | 22% | 18% | 17% | 20% | 15% | 15% | 13% | 14% | 17% | 11% | R&D / revenueR&D/rev |
| ($13M) | ($4M) | $7M | $12M | $7M | $33M | $44M | $28M | ($13M) | ($92M) | $14M | Operating incomeOp. inc. |
| −15.4% | −4.0% | 5.3% | 7.9% | 4.1% | 14.5% | 18.3% | 8.7% | −4.0% | −38.3% | 4.0% | Operating marginOp. mgn |
| ($12M) | ($2M) | $7M | $13M | $8M | $31M | $46M | $34M | ($9M) | ($82M) | — | Pretax incomePretax |
| ($12M) | ($2M) | $5M | $14M | $6M | $28M | $40M | $21M | ($20M) | ($80M) | $4M | Net incomeNet inc. |
| — | — | 25% | -8% | 28% | 12% | 13% | 37% | — | — | — | Effective tax rateTax rate |
| Cash flow & returns | |||||||||||
| $1M | $3M | $13M | $26M | $21M | $44M | $36M | $15M | $16M | ($34M) | ($3M) | Operating cash flowOp. cash |
| $3M | $3M | $2M | $4M | $3M | $4M | $4M | $5M | $7M | $8M | $9M | DepreciationDeprec. |
| $2M | ($1M) | ($1M) | ($2M) | ($168K) | ($2M) | ($29M) | ($35M) | $2M | $7M | ($44M) | Working capital & otherWC & other |
| $3M | $1M | $2M | $10M | $8M | $14M | $18M | $18M | $23M | $6M | $3M | CapexCapex |
| 3.9% | 1.2% | 1.8% | 6.7% | 5.1% | 5.9% | 7.6% | 5.6% | 7.5% | 2.4% | 1.0% | Capex / revenueCapex/rev |
| ($2M) | $2M | $11M | $22M | $18M | $40M | $31M | $9M | $9M | ($40M) | ($7M) | Owner earningsOwner earn. |
| −2.6% | 2.0% | 8.5% | 14.7% | 10.9% | 17.5% | 13.0% | 2.9% | 2.8% | −16.7% | −2.0% | Owner earnings marginOE mgn |
| ($2M) | $2M | $11M | $16M | $13M | $30M | $18M | ($4M) | ($8M) | ($40M) | ($7M) | Free cash flowFCF |
| −2.6% | 2.0% | 8.5% | 10.5% | 7.7% | 13.2% | 7.4% | −1.1% | −2.4% | −16.7% | −2.0% | Free cash flow marginFCF mgn |
| ($3M) | ($1M) | ($2M) | ($10M) | ($8M) | ($14M) | ($156M) | $74M | ($59M) | $46M | — | Investing cash flowInv. cash |
| $3M | $2M | $75M | $149K | $20M | $18M | $8M | $7M | $6M | ($5M) | — | Financing cash flowFin. cash |
| ($200K) | $279K | $197K | $203K | $367K | ($857K) | ($862K) | $202K | ($1M) | $1M | — | Exchange-rate effectFX |
| $597K | $5M | $85M | $16M | $32M | $47M | ($113M) | $97M | ($39M) | $9M | — | Change in cashΔ cash |
| -42% | -12% | 17% | — | — | 47% | 15% | 9% | -4% | — | 3% | ROICROIC |
| -32% | -5% | 4% | — | — | 11% | 12% | 6% | -5% | — | 1% | Return on equityROE |
| −32% | −5% | 4% | — | — | 11% | 12% | 6% | −5% | — | 1% | Retained to equityRetained/eq |
| Balance sheet | |||||||||||
| $14M | $19M | $104M | $120M | $152M | $200M | $212M | $221M | $230M | $188M | $181M | Cash & investmentsCash+inv |
| $16M | $18M | $26M | $31M | $35M | $44M | $62M | $95M | $78M | $50M | $98M | ReceivablesReceiv. |
| $8M | $6M | $7M | $8M | $7M | $9M | $12M | $14M | $17M | $12M | $13M | Accounts payablePayables |
| $8M | $12M | $19M | $23M | $28M | $35M | $51M | $81M | $61M | $38M | $85M | Operating working capitalOper. WC |
| $50M | $54M | $152M | $175M | $216M | $271M | $312M | $365M | $368M | $312M | $342M | Current assetsCur. assets |
| $21M | $19M | $28M | $34M | $41M | $49M | $52M | $65M | $70M | $69M | $73M | Current liabilitiesCur. liab. |
| 2.4× | 2.8× | 5.5× | 5.1× | 5.2× | 5.6× | 6.0× | 5.6× | 5.2× | 4.5× | 4.7× | Current ratioCurr. ratio |
| $12M | $10M | $11M | $17M | $24M | $36M | $51M | $67M | $85M | $73M | — | Net PP&ENet PP&E |
| $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | GoodwillGoodwill |
| $65M | $68M | $167M | $208M | $257M | $346M | $419M | $489M | $510M | $452M | $475M | Total assetsAssets |
| -113.0× | -32.4× | — | — | — | — | — | — | — | — | 122.6× | Interest coverageInt. cov. |
| $28M | $25M | $35M | $48M | $60M | $87M | $83M | $103M | $112M | $107M | — | Total liabilitiesTotal liab. |
| $38M | $43M | $132M | — | — | $262M | $336M | $386M | $397M | — | $365M | Shareholders’ equityEquity |
| 10.4% | 3.5% | 5.5% | 7.0% | 7.4% | 6.3% | 8.5% | 7.3% | 8.7% | 12.8% | 8.3% | Stock comp / revenueSBC/rev |
| Per share | |||||||||||
| 40.3M | 41.0M | 45.3M | 46.9M | 48.0M | 49.5M | 49.4M | 49.4M | 49.1M | 49.6M | 51.3M | Shares out (diluted)Shares |
| $2.04 | $2.21 | $2.74 | $3.20 | $3.41 | $4.66 | $4.85 | $6.52 | $6.39 | $4.83 | $6.62 | Revenue / shareRev/sh |
| $-0.30 | $-0.05 | $0.11 | $0.30 | $0.12 | $0.56 | $0.80 | $0.43 | $-0.41 | $-1.62 | $0.07 | EPS (diluted)EPS |
| $-0.05 | $0.04 | $0.23 | $0.47 | $0.37 | $0.82 | $0.63 | $0.19 | $0.18 | $-0.81 | $-0.13 | Owner earnings / shareOE/sh |
| $-0.05 | $0.04 | $0.23 | $0.33 | $0.26 | $0.61 | $0.36 | $-0.07 | $-0.16 | $-0.81 | $-0.13 | Free cash flow / shareFCF/sh |
| $0.08 | $0.03 | $0.05 | $0.22 | $0.18 | $0.28 | $0.37 | $0.37 | $0.48 | $0.12 | $0.07 | Cap. spending / shareCapex/sh |
| $0.94 | $1.05 | $2.93 | — | — | $5.29 | $6.81 | $7.81 | $8.09 | — | $7.12 | Book value / shareBVPS |
| 9-yr | 5-yr | |
|---|---|---|
| Revenue / share | +10.0%/yr | +7.2%/yr |
| Capital spending / share | +4.4%/yr | −7.7%/yr |
| Book value / share | +30.9%/yr (8-yr) | +15.2%/yr (3-yr) |
Where the cash went
ReinvestBuybacksDividendsAcquisitionsRetainedEach year's operating cash, by what management did with it: the mix, and how it drifts.
Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.
In fiscal 2025 the business turned a $80M loss into ($40M) of owner earnings: more cash than the profit line showed, after the non-cash charges and the capital it put back in.
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Reported net income | ($80M) | ($20M) | $21M | $40M | $28M |
| Depreciationnon-cash charge added back | +$8M | +$7M | +$5M | +$4M | +$4M |
| Amortization of intangible assetsnon-cash charge added back; the purchase price of past acquisitions, expensed over time | — | — | +$13K | +$28K | +$34K |
| Stock-based compensationreal costnon-cash, but a real cost | +$31M | +$27M | +$24M | +$20M | +$15M |
| Working capital & othertiming of cash in and out, other non-cash items | +$7M | +$2M | −$35M | −$29M | −$2M |
| Cash from operations | ($34M) | $16M | $15M | $36M | $44M |
| Maintenance capital expenditurethe spending needed just to hold position and volume | −$6M | −$7M | −$5M | −$4M | −$4M |
| Owner earnings | ($40M) | $9M | $9M | $31M | $40M |
| Growth capital expenditurediscretionary; spent to get bigger, not to stand still | — | −$17M | −$13M | −$14M | −$10M |
| Free cash flow | ($40M) | ($8M) | ($4M) | $18M | $30M |
| Owner-earnings marginowner earnings ÷ revenue | -17% | 3% | 3% | 13% | 18% |
Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $31M), owner earnings is nearer ($71M).
Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.
Dashed amortization years: the filer did not tag the intangible-amortization line that year, so that year's charge remains inside "Working capital & other."
Quality & stewardship
Returns, the balance sheet, capital allocation, and pay.
Owner’s Scorecard
Will it survive?
- No meaningful interest burdenLittle or no interest expense reported
What this means
Little or no interest expense reported, the business isn't leaning on lenders to operate.
- Net cashCash $153M + ST investments $34M − debt $5M
What this means
Cash and short-term investments exceed every dollar of debt by $183M, on net the company owes nothing, and can act from strength when others can't. Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.
- Not enough data
What this means
The filing data didn't include the inputs for this check.
Is it a good business?
- Not enough dataIndustry peers: median -21%
What this means
The filing data didn't include the inputs for this check.
- Solid through the cycle10-yr median margin, range -17%–18%; latest ($40M) = operating cash ($34M) − maintenance capex $6MIndustry peers: median -24%
What this means
What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's -17% of revenue this year, a 6% median across 10 years. Treating stock comp as the real expense it is (less $31M of SBC) leaves ($71M).
- Are earnings backed by cash? ($34M)Loss, and burning cashNet income ($80M) · cash from operations ($34M)
What this means
The company reported a net loss, so a conversion ratio isn't meaningful. What matters then is whether operations still threw off cash, here, they did not.
How is the cash used?
- No surplus to allocate
What this means
The business didn't generate positive Owner Earnings this year, so any distributions came from the balance sheet or borrowing, not from operations.
- Investing or harvesting? 0.70×HarvestingCapex $6M ÷ property depreciation $8M
What this means
Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.
The promise and the pay packet
- Heavy selling costSelling and marketing $103M ÷ revenue $239M
What this means
Sales and marketing as a share of revenue, kept apart from administrative overhead because it answers a different question: how much a business must spend to win the next customer. A company whose product pulls customers in spends little here and keeps the difference; one that must buy its growth is running to stand still, and the spending has to keep rising for revenue to keep rising. Read it beside the growth rate, not alone.
- Is the buyback buying ownership, or mopping up? 12.8%The buyback only stands stillStock compensation $31M (fiscal 2025), 12.8% of revenue · repurchases $6M · diluted shares +0.4% since 2022
What this means
Stock handed to employees is a real cost paid in the owner's own currency: it is charged against profit, but the shares it creates are permanent. Many companies repurchase stock at the same time, which looks like a return of capital and often is not — if the count barely moves, the cash merely cancelled the pay packet and bought the owner nothing. The three states worth telling apart are a count genuinely shrinking, a count standing still despite large repurchases, and a count rising because the issuance was never offset at all.
Graham’s defensive tests · 2 of 4 met
Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.
- Adequate size MissRevenue ≥ $2B · $239M
What this means
Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.
- Strong liquidity PassCurrent ratio ≥ 2× · 4.55×
What this means
Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.
- Conservative debt PassDebt ≤ working capital · $5M vs $243M WC
What this means
Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.
- Earnings stability MissA profit every year (10-yr record) · 4 loss years
What this means
Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.
- Dividend record —Uninterrupted dividends · no dividend line tagged in the data
What this means
An unbroken dividend was Graham's mark of durability. This record carries no dividends-paid line in any year — common for partnerships, whose distributions file under tags the chain doesn't read — so the criterion is withheld rather than judged on silence.
- Earnings growth —Earnings +33% over the record · —
What this means
Earnings were negative early in the record, a growth rate isn't meaningful.
- Moderate price —P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
What this means
Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $-0.53/share (latest year $-1.60), the averaged base the calculator's gate runs on. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.
Durability & moat, 2016–2025
Whether the record’s returns held, and what the capital reinvested earned.
- Profitable years 6 of 10
What this means
Lost money in 4 year(s), look at what happened there before trusting the average.
- Operating margin −5% → −11% (3-yr avg ends)
What this means
Through the cycle the operating margin slipped — about −5% early to −11% lately, median 4% — competition or costs are biting in.
- Worst year 2025 · −38.3% op. margin
What this means
Operations went underwater in 2025, understand why before trusting the good years.
- Share count +2.3%/yr
What this means
The share count is rising, dilution works against you on a per-share basis.
All figures as filed; the source filing is linked above.
Current Position
as of the latest quarter, Jul 3, 2026Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.
- Cash & short-term investments$181M
- Receivables$98M
- Other current assets$62M
- Accounts payable$13M
- Other current liabilities$60M
From the company's latest filing.
How the cash was used, 2016–2025
Over the record, the business generated $139M of operating cash; how management split it reads as a reinvestor, most operating cash is plowed back into the business.
- Reinvested$104M · 75%
- Buybacks$6M · 5%
- Retained (debt / cash)$29M · 21%
- Returned to owners$6M
6% of the owner earnings the business produced over the span, $0 as dividends and $6M as buybacks.
- Source of fundingOperating cash
Operating cash covered reinvestment and returns; over the span cash and short-term investments rose $167M.
- Average price paid for buybacks$17.20
Across the years where the filing reports a share count, 0M shares were bought for $6M, about $17.20 each.
- Net change in share count27.2%
The diluted count rose from 40M to 51M: issuance (stock pay, deals) outran any buybacks, so owners were diluted on net.
- Dividend record—
No dividend line was reported in the filing data over the span; the record here neither confirms nor rules out a payout.
Buybacks are gross of stock issued to staff; the share-count line above is the net of that, the figure that decides whether owners gained. The average price paid blends a year of purchases (and any accelerated repurchase), so it is close, not exact. The record of where the cash went and on what terms.
Management, ownership & pay
read the proxy →From the proxy: how much of the business the people running it own, and how they are paid, beside what the business earned for its owners in the same years.
| Fiscal year | Chief executive | Pay, as filed | “Actually paid” | Owner earnings |
|---|---|---|---|---|
| 2021 | Caren Mason | $5.5M | $11.6M | $40M |
| 2022 | Caren Mason | $6.5M | $1.0M | $31M |
| 2023 | Thomas G. Frinzi | $10.2M | $6.4M | $9M |
| 2024 | Thomas G. Frinzi | $7.8M | $2.7M | $9M |
| 2026 | Stephen C. Farrell | $7.5M | $5.4M | — |
| 2026 | Thomas G. Frinzi | $1.3M | $1.2M | — |
Both pay figures are the company’s own, from the pay-versus-performance table its proxy statement files. “As filed” is the Summary Compensation Table total: salary, bonus, and equity awards at their value on the day of grant. “Actually paid” is the SEC’s prescribed recalculation, which re-marks those equity awards to what they became as they vested; it can swing far above or below the filed figure in either direction, and negative years occur. Owner earnings are the whole business's, from the record above, for the same fiscal years.
- Insider ownership39.9%
The stake all directors and executive officers hold together, per the 2026 proxy: skin in the game, the first thing Munger reads.
- Stock-based compensation$31M
The slice of the business handed to employees in shares in fiscal 2025, 12.8% of revenue. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.
What an owner would ask, FY2026
read the 10-K →- How much of the revenue rides on one buyer?≈$109M · 32% of revenue on the largest customers (TTM)
“Two customers, our China distributors who sell into China and Hong Kong, accounted for approximately 32% of our consolidated net sales during fiscal 2025.”verify →
- Which reported numbers are a judgment call?Management names Pension & retirement, Income taxes, Stock compensation as critical estimates
each rests partly on management's judgment; the filing's note sets out the assumptionsverify →
The questions the record and the charts do not answer on their own; each carries the figure and the place to look.
Peers, Medical Devices & Equipment
The same industry, side by side on owner economics. Each column names the period it is read over; the group median at the foot is the line to read each figure against.
| Company | Revenuelatest FY, USD | Gross marginmedian over the record | Op. marginmedian over the record | ROICmedian over the record | Owner earn. marginmedian over the record |
|---|---|---|---|---|---|
| WRBYWarby Parker Inc. | $872M | 57% | -10.7% | -67% | 3% |
| LMATLeMaitre Vascular Inc. | $250M | 68% | 21.6% | 12% | 16% |
| STAASTAAR Surgical Company | $239M | 75% | 4.7% | 9% | 6% |
| KIDSOrthoPediatrics Corp. | $236M | 74% | -16.9% | -7% | -24% |
| CERSCerus Corporation | $234M | 58% | -40.9% | -43% | -31% |
| AXGNAxogen Inc. | $225M | 81% | -19.9% | -17% | -13% |
| ESTAEstablishment Labs Holdings Inc. | $211M | 65% | -33.0% | -36% | -35% |
| SIBNSI-BONE Inc. | $201M | 88% | -36.2% | -21% | -38% |
| Group median | — | 71% | -18.4% | -19% | -18% |
The price
What a price has to assume.
What the price implies
reverse-DCFType today's close and see the owner-earnings growth you'd have to believe to justify it, beside what STAAR Surgical Company has delivered.
STAAR Surgical Company’s latest year shows negative owner earnings, a cyclical trough. So the tool opens on the through-cycle base, the cash it would earn at rest; clear the toggle below to read the latest year exactly as reported.
Through the cycle, STAAR Surgical Company earns about $14M on its 5.7% median owner-earnings margin. This year’s −16.7% margin runs below that; the reported figure may understate a lean year. Normalize, below, values the price on that through-cycle figure rather than the latest year.
—
9.0% = the 4.71% 10-year Treasury (Aug 18, 2026) + 4.29 points of equity premium. The rate you require is yours to set.
Enter a price above to run it.
A dated snapshot of the price you typed, the assumptions you set, and what the page showed for them. A snapshot is never edited after it is saved. Your notebook is yours alone — the commitment states what is stored and what we will never do.
Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.
Prefilled with the 10-year Treasury (4.71%, as of Aug 18, 2026). Edit it for today’s exact figure, or a AAA corporate yield.
Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.
Owner earnings ($7M) on 50M shares outstanding, per the 10-Q cover, as of 2026-08-07; net cash $181M. The base opens on the through-cycle figure (the latest year sits off the record’s own median, and Graham’s averaging cuts both ways); clear Normalize to use the year as filed. Net of stock comp treats option pay as the expense it is. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.
Manual order: ← ST its page in the Manual STAG →
Industry order: ← SSII the Medical Devices & Equipment chapter STE →